抗体-配体基序的设计优化以增强 CAR-T 抗实体瘤重定向活性 Design optimization of antibody-ligand motifs to enhance CAR-T redirection activity against solid tumors. PubMed 2026/06/25 发表Cell Rep MedQ1 · IF 14(JCR 2025) 靶点:HER2靶点:ROR1靶点:VEGFR技术:CAR-T实体瘤地区:中国
血液系统恶性肿瘤中靶向 ROR1 的治疗进展 Therapeutic advances in the targeting of ROR1 in hematological cancers. PubMed 2024/11/17 发表Cell Death DiscovQ1 · IF 10.4(JCR 2025) 靶点:HER2靶点:EGFR靶点:ROR1技术:CAR-T技术:双特异性抗体血液系统恶性肿瘤